Clinical trial · Interventional
Identification, Molecular Epidemiology Angiosarcoma of the Liver France
NCT01786889CI-TRIAL-00023295ANGIHEunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to test the feasibility of identifying incident cases of angiosarcoma of the liver from the network NetSarc.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Angiosarcoma | Angiosarcoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| blood and urine | Biological | — | UNRESOLVED |
| Questionnaire | Behavioral | — | UNRESOLVED |
| Telephone interview | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Patient with angiosarcoma of the liver
- description
- Blood and urine collections, questionnaire and telephone interview
- interventionNames
- Biological: blood and urine
- Behavioral: Questionnaire
- Behavioral: Telephone interview
Primary outcomes (1)
- measure
- Feasibility of identifying incident cases of angiosarcoma liver from the network NetSarc
- timeFrame
- At month 36
- description
- Feasibility of identifying incident cases of angiosarcoma of the liver (ASF) from the network NetSarc: number of sheets indicated and returned to the Promoter. 30 cases are expected, the cumulative number of incident cases will be measured over a period of 36 months
Secondary outcomes (4)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Any patient with angiosarcoma of the liver (angiosarcoma immediately multifocal allowed) diagnosed by histology from the start of the study * The patient's written Consent No exclusion criteria
References
Publications (0)
Data not yet available
No reference posted for this study.